AMZN
Amazon.com, Inc.
AMZN has slightly lower modeled downside risk, despite its lower overall score.
STX
Seagate Technology Holdings plc
STX has the edge over AMZN overall, supported by stronger fundamentals and stronger modeled upside.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
STX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
STX's revenue, profitability, cash flow and balance sheet are all currently strong.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over STX in the historical PE scenario, which offers more potential upside but is not a forecast.
STX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.9x | $188 | -65% |
| Forward | 12x | $545 | — |
| Fair | 17x | $318 | -42% |
| Current | 29x | $545 | — |
| Expensive | 43x | $823 | +51% |
Historical ranges are pointers, not guarantees.
STX's PE is in its expensive range at 29x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its cheap range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
STX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
STX has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN's earnings per share have climbed steadily: $12.37 over the past year, up 75% from the year before, and higher year over year for 14 quarters in a row. Its recent earnings include one-off gains.
STX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.99 | +147% |
| Q3 2026 | $19.06 | +145% |
| Q2 2026 | $13.90 | +105% |
| Q1 2026 | $10.54 | +51% |
| Q4 2025 | $8.84 | +60% |
| Q3 2025 | $7.79 | +101% |
| Q2 2025 | $6.77 | +328% |
| Q1 2025 | $6.96 | +$8.26 |
| Q4 2024 | $5.51 | +$9.02 |
STX's earnings per share have climbed steadily: $19.06 over the past year, up 145% from the year before, and higher year over year for 10 quarters in a row.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
STX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.2B | +61% |
| Q2 2026 | $3.6B | +48% |
| Q1 2026 | $3.1B | +44% |
| Q4 2025 | $2.8B | +22% |
| Q3 2025 | $2.6B | +21% |
| Q2 2025 | $2.4B | +30% |
| Q1 2025 | $2.2B | +31% |
| Q4 2024 | $2.3B | +50% |
STX has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 49% | +22 points |
| Q2 2026 | 43% | +20 points |
| Q1 2026 | 32% | +12 points |
| Q4 2025 | 30% | +8.9 points |
| Q3 2025 | 26% | +7.8 points |
| Q2 2025 | 23% | +6.6 points |
| Q1 2025 | 20% | +11 points |
| Q4 2024 | 21% | +13 points |
STX has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
STX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +246% |
| Q2 2026 | $1.1B | +163% |
| Q1 2026 | $953M | +341% |
| Q4 2025 | $607M | +305% |
| Q3 2025 | $427M | +1481% |
| Q2 2025 | $425M | +12% |
| Q1 2025 | $216M | +69% |
| Q4 2024 | $150M | +52% |
STX has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over STX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
STX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +3M shares |
| 1 year | +2.7% | +6M shares |
| 3 years | +12% | +24M shares |
| 5 years | +0.4% | +1M shares |
| Available history | -12% | -33M shares |
STX has 232M diluted shares, up 2.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $400M |
| Q2 2026 | $117M |
| Q1 2026 | $30M |
| Q4 2025 | — |
| Q3 2025 | $29M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
STX spent $547M buying back its own shares over the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
STX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.8x | Moderate |
STX has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
STX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.5 | Neutral |
| Stochastic | 8.3 | Oversold |
STX's weekly RSI is 40 (neutral) and its Stochastic is 8 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
STX PE vs Technology Sector
| Metric | STX | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 28x | 2.7% above |
| PE % | 75 | 35 | 40 pts above |
STX has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over STX on trend strength, trading above more of its moving averages.
STX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $683.6 | 20% below |
| 20 week MA | $785.0 | 31% below |
| 50 week MA | $630.7 | 14% below |
| 100 week MA | $387.3 | 41% above |
| 200 week MA | $234.4 | 133% above |
STX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 133% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
STX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $59.6 | $63.0 | +5.7% |
| 2021 | $63.0 | $111.4 | +77% |
| 2022 | $111.4 | $50.5 | -55% |
| 2023 | $50.5 | $85.4 | +69% |
| 2024 | $85.4 | $87.4 | +2.4% |
| 2025 | $87.4 | $286.2 | +228% |
| 2026 YTD | $286.2 | $545.1 | +90% |
STX has the edge over AMZN on returns for 2026, with the stronger performance.